{"id":"W2314906058","doi":"10.1136/annrheumdis-2014-eular.1890","title":"AB0235 Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A Report from the Rhumadata® Clinical Database and Registry","year":2014,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université du Québec à Rimouski","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Infliximab; Rituximab; Rheumatoid arthritis; Internal medicine; TNF inhibitor; Visual analogue scale; Rheumatology; Cohort; Clinical trial; Database; Physical therapy; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001161536,0.000185087,0.0009066413,0.0007845276,0.0001690134,0.0007388702,0.0004155982,0.000442141,0.002094877],"category_scores_gemma":[0.003888205,0.0002208397,0.001406811,0.002304938,0.0001355546,0.0003995203,0.0002908558,0.0007901938,0.0003118924],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005289703,"about_ca_system_score_gemma":0.0005661284,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00701812,"about_ca_topic_score_gemma":0.007750786,"domain_scores_codex":[0.9978307,0.0007073533,0.0004922199,0.0003592836,0.0004187909,0.0001916113],"domain_scores_gemma":[0.9956462,0.001308769,0.002422723,0.0001239092,0.0002209995,0.0002773695],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02284463,0.0002880618,0.9400671,0.0008270325,0.003348181,0.0002083371,0.0001083156,0.0003741923,0.0009019992,0.0001898516,0.006605542,0.02423677],"study_design_scores_gemma":[0.001493573,0.001104285,0.9906415,0.00018587,0.00237444,0.0005681991,0.0001656562,0.000440179,0.0002964317,0.00008130783,0.002626208,0.00002224979],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9539077,0.03074512,0.0001216272,0.0005046454,0.000113782,0.00003762844,0.01160239,0.00002430661,0.002942811],"genre_scores_gemma":[0.9880058,0.004495498,0.0001124698,0.0003336654,0.00009529789,0.0000387966,0.006515044,0.000008771089,0.0003945722],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00701812,"threshold_uncertainty_score":0.01395452,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06414060930602469,"score_gpt":0.3404344388877495,"score_spread":0.2762938295817248,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}